Join
Live feed
·
PRReleasevia Quantisnow
Acorda Therapeutics Inc. logo

Acorda Second Quarter 2023 Update: Webcast/Conference Call Scheduled for August 8, 2023

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACOR (Acorda Therapeutics Inc.) and more on Quantisnow.